This review will discuss IGFs action in cancer particularly focusing on how novel regulators integrate the IGF system and how these biological networks affect tumor development and progression, response to therapies and metabolism and might provide novel therapeutic opportunities to block this system. This evidence concerns the gene IGF1 and neoplasm.